Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
We applied proteomics technologies to analyze the cerebrospinal fluid of patients with schizophrenia. Such an analysis can result in the identification of proteins, which may play a role in the disease progress and thus lead to the discovery of clues of the etiology of schizophrenia. Cerebrospinal fluid from patients and controls was analyzed by two-dimensional gels and the proteins were identified by matrix-assisted laser desorption ionization mass spectrometry (MS) in the MS and MS/MS mode. 54 different gene products were identified, which were mainly plasma proteins. The level of apolipoprotein A-IV was significantly decreased in the schizophrenic patients compared to that in the controls. Little is known about the function of this apolipoprotein in the central nervous system. The levels of certain other proteins, like haptoglobin, fibrinogen, complement component 3, and Gc-globulin, were altered in the disease group as well, however, the changes did not reach a statistical significance.
Jiang
L
L
Bio-X Life Science Research Center, Shanghai Jiao Tong University, Shanghai, China.
Lindpaintner
K
K
Li
H-F
HF
Gu
N-F
NF
Langen
H
H
He
L
L
Fountoulakis
M
M
D001054:Apolipoproteins A / Q000134:cerebrospinal fluid; D002490:Central Nervous System / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000737:chemistry*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis*; D015180:Electrophoresis, Gel, Two-Dimensional; D006801:Humans; D040901:Proteomics; D012559:Schizophrenia / Q000134:cerebrospinal fluid*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D001054:Apolipoproteins A; D002556:Cerebrospinal Fluid Proteins; C022205:apolipoprotein A-IV